Evaluation of Calprotectin Level in Intestinal Content as an Early Marker for Graft Rejection

Transplantation Proceedings

Volumn 42, Issue 1, 2010, Pages 57-61

  Cagnola, H ^a   Scaravonati, R ^b   Cabanne, A ^b   Bianchi, C ^b   Gruz, F ^b   Errea, A ^a   Zambernardi, A ^a,b   Meier, D ^a   Chirdo, F ^a   Docena, G ^a   Gondolesi, G ^b,c   Rumbo, M ^a,c  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c FAVALORO UNIVERSITY   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; ASSAY; BIOPSY; CHILD; CONTROLLED STUDY; CONVALESCENCE; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FECES LEVEL; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE; INTESTINE MUCOSA; INTESTINE TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEDICAL RECORD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SAMPLE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; GRAFT REJECTION; HUMANS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; TRANSPLANTATION, HOMOLOGOUS;

EID: 76749103732     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.12.013     Document Type: Article

References (14)

1. Selvaggi G., and Tzakis A.G. Intestinal and multivisceral transplantation: future perspectives. Front Biosci 12 (2007) 4742
2. Fishbein T.M. Intestinal transplantation. N Engl J Med 361 (2009) 998
3. Striz I., and Trebichavsky I. Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53 (2004) 245
4. Foell D., Wittkowski H., and Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 58 (2009) 859
5. Madland T.M., Hordvik M., Haga H.J., et al. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand J Rheumatol 31 (2002) 351
6. Sudan D., Vargas L., Sun Y., et al. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 246 (2007) 311
7. Akpinar E., Vargas J., Kato T., et al. Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study. Transplantation 85 (2008) 1281
8. Ruiz P., Bagni A., Brown R., et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant 1 Symposium. Transplant Proc 36 (2004) 335
9. Gondolesi G., Fishbein T., Chehade M., et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Transplant Proc 34 (2002) 918
10. Crenn P., Messing B., and Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27 (2008) 328
11. Gondolesi G., Ghirardo S., Raymond K., et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transplant 6 (2006) 2786
12. Gondolesi G.E., Kaufman S.S., Sansaricq C., et al. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant 4 (2004) 414
13. Corti B., Altimari A., Gabusi E., et al. Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients. Transplant Proc 37 (2005) 4467
14. Altimari A., Gruppioni E., Capizzi E., et al. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. Transplantation 85 (2008) 1778